Since the expression of LANCL2 and PPAR-γ in asthmatics differs from that of COPD patients, the ABA-related outcome might be different in asthmatics (Supplementary Figures 3B,C, 7C), which requires further investigations. This evidence concerns the gene LANCL2 and chronic obstructive pulmonary disease.